Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update on paclitaxel plus estramustine for metastatic prostate cancer.
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: SU006668 in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 update on the investigational drug SU006668 being studied in patients with advanced solid tumors, including breast cancer and colore…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence [Phase 2]
Phase 2 clinical trial update evaluating R-Flurbiprofen for localized prostate cancer at risk of recurrence.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Figitumumab Combined With Pegvisomant For Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the combination of figitumumab with pegvisomant for advanced solid tumors was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating monthly intramuscular degarelix dosing in patients with prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of oxaliplatin and pemetrexed disodium in patients with refractory hormone-resistant pro…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Sandostatin for Patients With Androgen Independent Prostate Cancer [Phase 2]
A Phase 2 trial of Sandostatin (octreotide) in androgen-independent prostate cancer was terminated and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: A Study of Degarelix in Taiwanese Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating degarelix in Taiwanese patients with prostate cancer has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Phase 2]
A Phase 2 trial comparing leuprolide acetate or goserelin acetate against observation in high-risk prostate cancer patients after radical pr…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function [Phase 1]
Phase 1 study evaluating the pharmacokinetics of abiraterone acetate in men with mild or moderate hepatic impairment compared with matched c…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel [Phase 2]
A phase 2 trial evaluating cediranib maleate with or without dasatinib in hormone-refractory prostate cancer that is resistant to docetaxel …
-
CLINICAL_TRIALS research · 2013-12-05Clinical Trial Update: Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer [NA]
This clinical trial update outlines the development of a clinical assessment technique using multi-radiotracer PET/MR imaging for prostate c…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy
A completed clinical trial evaluating intra-operative trans-rectal ultrasound guidance during robot-assisted radical prostatectomy for prost…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
A Phase 2 clinical trial update evaluating combination chemotherapy for patients with hormone-refractory prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Radiation Therapy in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating radiation therapy for prostate cancer has completed.
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer [Phase 1, Phase 2]
A clinical trial update for mitoxantrone with granulocyte colony-stimulating factor in metastatic prostate cancer, covering Phase 1 and Phas…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating GEMOX (gemcitabine and oxaliplatin) in docetaxel-refractory castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Trilostane for Androgen-Independent Prostate Cancer [Phase 2]
Phase 2 trial update assessing trilostane in androgen-independent prostate cancer has completed enrollment and results.
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: The Effect of Endurance Training in Patients With Prostate Cancer [NA]
A completed clinical trial evaluating the effects of endurance training in patients with prostate cancer, with reported observations on insu…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated dasatinib in combination with docetaxel for metastatic hormone-refractory prostate cancer; results were posted i…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial investigating docetaxel plus hydroxychloroquine in metastatic prostate cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer [Phase 2]
A Phase 2, open-label, single-center study assessed GE-148 (18F) PET imaging to detect localized prostate cancer; the trial was terminated w…
-
CLINICAL_TRIALS withdrawal · 2013-11-21Clinical Trial Update: Botulinum Toxin Injection With Prostate Brachytherapy [Phase 2]
Phase 2 trial evaluating botulinum toxin injections with prostate brachytherapy for prostate cancer-related urinary symptoms has been withdr…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy [Phase 2]
A Phase II trial evaluating neoadjuvant regimens of eflornithine with bicalutamide versus eflornithine alone, bicalutamide alone, or no neoa…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade [Phase 2]
Phase 2 trial evaluating pazopanib as second-line therapy in metastatic prostate cancer refractory to androgen blockade was terminated, with…